Erleada 60 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ6V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,966
Award facts
- Contract value 100% obligated
- $7,965.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Erleada 60 mg tablets (120-count units) valued at $7,965.80, with completion scheduled for February 5, 2026. This firm fixed-price contract award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. The award represents a delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026.
AmerisourceBergen's substantial IDC with the Defense Logistics Agency enables the company to supply an extensive range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The company operates under its parent organization, Cencora, Inc. (doing business as AmerisourceBergen), which holds the primary contractual relationship with DLA Troop Support Medical and maintains additional federal contracts with agencies including the Department of Veterans Affairs and the Federal Bureau of Investigation. This delivery order for Erleada, an oncology treatment medication, exemplifies the types of specialized pharmaceutical products distributed through AmerisourceBergen's federal contract vehicle to support military treatment facilities and government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FCZ6V?
SPE2DR26FCZ6V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FCZ6V worth?
The government has obligated $7,966 on SPE2DR26FCZ6V.
Is contract SPE2DR26FCZ6V an order under another contract?
Yes. SPE2DR26FCZ6V is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ6V competed?
The extent of competition for SPE2DR26FCZ6V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award